This fund suits those who want to invest in growth companies globally

Our lives have changed because of the technological advancements made in recent decades. New companies have emerged that have delivered products and services that have revolutionized the way we consume television and music, how we communicate and even how we buy goods and services. And these technological developments will continue, creating good growth opportunities for innovative well-managed companies the world over. As an example, in 2004 Volvo and Apple had about the same market values. In 2018, Apple is worth about 20 times more than Volvo. The world is changing.

Investment Policy

Lannebo Vision is an actively managed equity fund that invests in growth industries globally, but where the emphasis is on the U.S.. Prevailing industries that the fund invests in include technology, telecommunications, health, Internet and media.

Management Style

We strive to find companies that are leaders in their industries. We analyse the company's competitiveness and future prospects and we evaluate how this is reflected in the share price. The intention is that each investment must qualify on its own merits, where focus is placed on what is important for each individual company and their long-term development. The fund’s objective is to generate a better return than similar funds.

The fund targets those who

• want a global exposure to growth companies primarily in the technology sector
• believe in active management and investments based on a clear understanding of each individual company


Minimum investment in the fund is 100 Swedish kronor.

Fund manager

Risk Information: Past performance is no guarantee of future returns. The money you invest in a fund can both increase and decrease in value and it is not certain that you will get back the full amount invested.


Previous Day
Start of the year
5 Y

Fund facts

Inception date
Starting price
Fixed fee
PPM nr.
771 030

Risk/return profile

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Lower risk Higher risk